4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002034679-25-000003
Chief Medical Officer sold 22,000 shares at $18.45 ($405,900)
- Chief Medical Officer acquired 22,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Raben David Chief Medical Officer | 2025-10-09 | Option exercise 10b5-1 | +22,000 | $3.79 | $83,376 | 57,497 | D |
| Raben David Chief Medical Officer | 2025-10-09 | Sale 10b5-1 | −22,000 | $18.45 | $405,900 | 35,497 | D |
| Derivatives | |||||||
| Raben David Chief Medical Officer | 2025-10-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −22,000 | 128,870 | D | ||
| Open-market sales · 22,000 sh · avg $18.45 · $405,900 | |||||||
Loading xslF345X05/wk-form4_1760131397.xml…